Professor Thomas Seyfried: “Mebendazole, Febendazole [I] did a dive on it and I said, why [do] Parasite medications work against cancer cells, and it turns out that the parasites use mitochondrial substrate level phosphorylation in the tissue .. and mebendazol fenbendazol kill these parasites. So I tried it on the cancer cell and sure as hell, it targets the mitochondrial substrate and glycolysis.” Parasites rely on the EXACT same dysfunctional energy pathway cancer cells do and these drugs don’t care that cancer isn’t a parasite. “So we have a mechanism now why parasite medications are working, but cancer is not a parasite.” Thomas Seyfried mentions avoiding researching Ivermectin because of political pressure during covid, but Dr. Isabella Cooper, PhD in Ketogenic Science and Hyperinsulinemia points out the mechanism for him:
“Ivermectin, it actually works on the mitochondrial cell death pathway”.